Alexion Pharmaceuticals
ALXN
#620
Rank
A$59.70 B
Marketcap
A$270.12
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Alexion Pharmaceuticals (ALXN)

Earnings in 2021 (TTM): A$0.67 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current earnings are A$6.26 Billion. In 2020 the company made an earning of A$0.99 Billion a decrease over its 2019 earnings that were of A$3.33 Billion.

Earnings history for Alexion Pharmaceuticals from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)A$0.67 B-32.05%
2020A$0.99 B-70.15%
2019A$3.33 B562.93%
2018A$0.50 B-47.32%
2017A$0.95 B-3.98%
2016A$0.99 B23.29%
2015A$0.80 B-37.62%
2014A$1.29 B64.99%
2013A$0.78 B30.97%
2012A$0.59 B75.72%
2011A$0.34 B53.93%
2010A$0.22 B78.4%
2009A$0.12 B125.97%
2008A$54.96 M-137.23%
2007-A$0.15 Billion-27.23%
2006-A$0.21 Billion10.16%
2005-A$0.19 Billion69.7%
2004-A$0.11 Billion-9.64%
2003-A$0.13 Billion10.27%
2002-A$0.11 Billion96.74%
2001-A$55.37 Million